Chicago, IL – March 12, 2025 – Zacks Equity Research shares Jazz Pharmaceuticals JAZZ as the Bull of the Day and The Boston Beer Company SAM as the Bear ...

Jazz Pharmaceuticals, a Zacks Rank #1 (Strong Buy), is a specialty biopharmaceutical company that identifies, develops, and ...

The stock market selloff heated up to start the week as Wall Street locked in profits amid the chaos caused by the tariff ...

Limited or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' ...

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced it is buying Chimerix (Nasdaq: CMRX) for $8.55 per share in cash, ...

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Despite fluctuations, the bull run continued in 2025. However, U.S. stocks suffered a blow and the bull ...

It is one of the best cash rich stocks to invest in. On December 6, 2024, the company shared new research on Epidiolex ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Medical cannabis is legal in the UK. This means that in some circumstances, specialist doctors may prescribe it to treat epilepsy. On this page, we talk about the different types of medical cannabis ...

We maintain our fair value estimate of $187 per share. Xywav (for excessive daytime sleepiness), Epidiolex (for childhood epilepsy), and Rylaze (for leukemia) have continued to be Jazz’s primary ...